Dec 8, 2011

So, I decided to take BIT for a spin and to reply to one of their invitations. Here is the one that I received:

On Nov 3, 2011, at 4:24 AM, Ella wrote:
2nd Annual Symposia of Bacteriology and Infection (SBI-2012)
Time: July 30-August 1, 2012
Place: Guangzhou, China

Dear Dr. [my name],

BIT’s 2nd Annual Symposium of Bacteriology and Infection (SBI-2012) hosted by Information Research Center of International Talent, SAFEA and China Medicinal Biotech Association will take place from 30 July to 1 August, 2012 in Guangzhou, China. As the operating organization, BIT World Congress cordially invites you to be a speaker at SBI 2-1: Old vs New Antibacterial Targets of Superbugs of the congress and deliver a lecture in your expertise.

The first conference of SBI-2011 has been held successfully in the past year as one of the sub-conferences of Annual World Congress of Microbes in Beijing China with more than 400 participants from 48 countries and regions. The second congress promises to be an even greater event that will emphasize practical and advanced ideas for accelerating bacteria research and development. It now is time for more experts and scholars as well as industrials leaders to join the 2nd SBI-2012 in Guangzhou to take the subject into a higher study standard.

The program of SBI-2012 this will conclude 4 major aspects, please check the detailed program followed:

SBI-1Breaking Research on Superbugs
SBI 1-1: Prevention, Surveillance and Statistics of Resistance to Antibiotics and Biocides
SBI 1-2: Revisitingbβ-Lactamase-Associated Resistance Mechanisms
SBI 1-3: Methicillin-resistant Staphylococcus aureus (MRSA)
SBI 1-4: Vancomycin Intermediate/Resistant Staphylococcus aureus (VISA/VRSA), and Vancomycin-resistant Enterococcus (VRE)
SBI 1-5: Helicobacter spp.and other Gastrointestinal Infectious Diseases
SBI 1-6: Escherichia coli O157: H7 and other STEC
SBI 1-7: Cronobacter spp (Enterobacter sakazakii)
SBI 1-8: Salmonella: from Basic Science to Clinical Issues

SBI-2Drug Discovery and Development for MDR Strains and Superbugs
SBI 2-1: Old vs New Antibacterial Targets of Superbugs
SBI 2-2: Development of Effective Antibiotics against MRSA, VRE and VRSA
SBI 2-3: New Strategies of Discovering Antibacterial Agents from Natural Products
SBI 2-4: Clinical Trials on Novel Antibacterials

SBI 3-1: Immunology, Cell Biology and Innovative Vaccines of Tuberculosis
SBI 3-2: Mycobacterium Tuberculosis
SBI 3-3: Diagnosis of Tuberculosis

SBI-4Translational Medicine for Antibacterial Drug Development
SBI 4-1: New Approaches to Antibacterial Drug Discovery
SBI 4-2: Multidrug Resistance
SBI 4-3: New Drug Development for Bad Bugs

If you would like to give an oral presentation at this conference, please submit title by email to All proposals are subject to review by the scientific advisory board to ensure the overall quality of the conference. For further questions,please visit Website:

We look forward to seeing you join us at this influential event in Guangzhou next year.

Ms. Ella Cheng 
Program Coordinator
Organizing Committee of SBI-2012, China
East Area, F11, Building 1, 
Dalian Ascendas IT Park, 
1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, China 
Tel: 0086-411-84799609-813
Fax: 0086-411-84799629

No comments:

Post a Comment